Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L Shacklett

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 13, 2016
Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometriumUma Shanmugasundaram, Joan F Hilton, J William Critchfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infectionBarbara L Shacklett, Catherine A Cox, Máire F Quigley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2025
Gastrointestinal MAIT cells in chronic HIV-1 infectionApril L Ferre, Emily A Fehrman, Peter W Hunt, et al.
Journal of Virology|September 2, 2011
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollersJulia M Shaw, Peter W Hunt, J William Critchfield, et al.
Plos One|July 16, 2015
Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover StudyKaren Smith-McCune, Joseph C Chen, Ruth M Greenblatt, et al.
AIDS Research and Human Retroviruses|September 25, 2012
Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activationJulia M Shaw, Peter W Hunt, J William Critchfield, et al.
Plos One|August 23, 2019
Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivoMarielle Cavrois, Joan F Hilton, Nadia R Roan, et al.
Contraception|October 2, 2020
Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assayDominika Seidman, Marielle Cavrois, Joan F Hilton, et al.
AIDS Research and Human Retroviruses|October 25, 2002
Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251Barbara L Shacklett, Binhua Ling, Ronald S Veazey, et al.
Journal of Virology|October 22, 2002
Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251Barbara L Shacklett, Karen E S Shaw, Lou A Adamson, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 13, 2016
Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometriumUma Shanmugasundaram, Joan F Hilton, J William Critchfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infectionBarbara L Shacklett, Catherine A Cox, Máire F Quigley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2025
Gastrointestinal MAIT cells in chronic HIV-1 infectionApril L Ferre, Emily A Fehrman, Peter W Hunt, et al.
Journal of Virology|September 2, 2011
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollersJulia M Shaw, Peter W Hunt, J William Critchfield, et al.
Plos One|July 16, 2015
Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover StudyKaren Smith-McCune, Joseph C Chen, Ruth M Greenblatt, et al.
AIDS Research and Human Retroviruses|September 25, 2012
Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activationJulia M Shaw, Peter W Hunt, J William Critchfield, et al.
Plos One|August 23, 2019
Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivoMarielle Cavrois, Joan F Hilton, Nadia R Roan, et al.
Contraception|October 2, 2020
Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assayDominika Seidman, Marielle Cavrois, Joan F Hilton, et al.
AIDS Research and Human Retroviruses|October 25, 2002
Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251Barbara L Shacklett, Binhua Ling, Ronald S Veazey, et al.
Journal of Virology|October 22, 2002
Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251Barbara L Shacklett, Karen E S Shaw, Lou A Adamson, et al.
Pageof 9